The chronic hepatitis D virus market is expected to grow steadily, driven by a relatively small pipeline of emerging therapies. Leading candidates, such as Brelovitug from Bluejay Therapeutics ...

DelveInsight's Chronic Hepatitis D Market Insights report includes a comprehensive understanding of current treatment ...

Wisconsin guard Laci Steele fights to keep possession against Oregon's Sofia Bell, left, and Mia Jacobs during a Big Ten ...

Dominic has spent a few months with the Sennheiser hd 800 S headphones and the hdv 820 amplifier - a pairing costing around £3,500. Just how good are they?

Detailed price information for S&P 500 Ishares Core ETF (IVV-A) from The Globe and Mail including charting and trades.

Professional video editing, simplified ...

Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease ...

The Trump Administration proposed massive cuts to Immigration and Customs Enforcement’s body camera programme for this ...

In January 2026, Vir Biotechnology reported new positive data from its ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta, where combination therapy with investigational agents tobevibart and ...

Beta measures price volatility relative to the S&P 500; beta is calculated from five-year weekly returns. The 1-yr return represents total return over the trailing 12 months. VIG is marginally less ...

Chevron shares are up on Thursday as the company navigates complex geopolitical landscapes, particularly regarding potential investments in Venezuela.